chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient anxious prior to receiving vaccine.  Approximately one minute after injection complete, patient had syncopal episode that lasted less than one minute.  Regained consciousness and was placed with legs elevated above heart.  Provided and encouraged patient to consume water.  Ice pack applied to back of head while patient rested in dads arms.  After approximately 5 minutes, patient had pinkness to her cheeks and lips vs the minute following the syncopal episode when her skin tone changed to pale.  Encouraged patient to continue consuming fluids and begin slowly moving feet and hands around.  After 15 minutes patient appeared more alert, ambulating independently without complaint of dizziness or lightheadedness.  Denied nausea, numbness.  Patient remained with this writer and her father while continuing to consume water and converse.  Mother came into vaccine room and was educated regarding event.  Encouraged parents to provide well rounded meal, push fluids and allow patient to rest.  Parents and patient acknowledged reasoning and rationale.   Patient remained slightly lethargic upon discharge.  Was ambulating independently, conversing and oriented.  Patients doctor office contacted by this writer and informed of adverse event.  No further questions remained from nurse, patient or parents.
I developed a red rash, swelling, and pain at injection site following the shot.  This lasted approximately 3 days and then went away.  Three to four days later, the redness, swelling, pain and itching returned.  The diameter of the redness and swelling is tennis ball size.  It seems unusual that the initial reaction went away in 3 to 4 days and then returned again 3 to 4 days later.
Low grade fever (99.6 degrees F) with chills and body aches starting roughly 14 hours after receiving second dose of covid vaccine and lasting 24 hours. Headache starting roughly 24 hours after receiving vaccine and lasting 12 hours. Fatigue starting 12 hours after receiving vaccine and lasting roughly 24 hours. Rash extending down from both armpits to mid-ribcage starting 24 hours after receiving vaccine, still ongoing although getting slightly better.
I had a pounding headache  and fever.  I had the chills and could not stop shaking throughout the night.  I was exhausted and all my muscles ached.  I took Tylenol, but it did not help much.  I slept most of the next day and though the night, and when I woke I only had a headache .
Timeline: 3/2/21 (approximately): redness and itchiness around my eye diagnosed as eczema, told to put aquaphor on it 3/3/21: VACCINE 3/6/21: started Junel FE birth control pills 3/7/21: developed a rash on my torso, shoulders, and neck 3/8/21: eye eczema was worse, doctor prescribed 2-week course of Bactrim and amoxicillin for periorbital cellulitis; rash on torso/neck/shoulders had worsened, dr said it looked like a drug rash and to discontinue the Junel FE and to take an antihistamine. This was my first time taking Bactrim. 3/18/21: shoulder rash was stable, neck rash was worsening and spread to my chest. My dr prescribed clobetasol.   I had the second covid shot on 3/24/21 with no side effects other than a sore arm. the issues described above had cleared by by the time I received the 2nd shot.
I was fine for the 15 mins they had me wait, but after I left, not to long after my face and hands broke out in hives. I let my mom know and my kids father know. I waited to see if the hives would go away and they did.
Tremendous knot to come up right at the site injection/ hard knot of about 1-1.5 inch; This is a spontaneous case, initially received from a pharmacist on 30-Oct-2018, concerns a 38-year-old, adult male patient.  The patient's current condition included high cholesterol. The patient's concomitant medications included Lipitor (atorvastatin calcium) and Xanax (alprazolam) for unknown indications.  On 30-Oct-2018, the patient was administered Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: YF36905 and expiry date: 16-May-2019) for active immunization against influenza.  On the same day, immediately after vaccination, when the pharmacist went to put plaster on it, a tremendous hard knot of about 1-1.5 inches came up at the injection site (injection site lump). The patient had no other symptoms like redness or rash or inflammation. The patient had not taken any treatment measures for the event. On the same day evening, the patient reported that he felt fine and knot started to go quite a bit (as reported). Approximately 6 hours after vaccination, the knot had resolved. It was reported that, the knot was not noticeable anymore.  At the time of this report, the patient had recovered from the event.  The reporter assessed this case as non-serious.  Follow-up report received from reporter on 19-Nov-2018: The reporter confirmed that the patient had recovered from the event approximately 6 hours after vaccination. The outcome of the event (injection site lump) was changed from not recovered' to recovered'. Added concomitant medication (Xanax) but the information regarding its indication was not available. The narrative was amended accordingly.; Reporter's Comments: A 38-year-old, male patient developed an injection site lump, immediately after vaccination with Afluria Quadrivalent. The company assessed the causality of the event as related to the suspect vaccine due to localized nature of the event and plausible temporal relationship between the event and suspect vaccine.
He woke in the middle of morning, got rigid and started convulsing. We went to the ER and was told he had three seizures.  Going to see a specialist to see if he epilepsy.
Seven days after receiveing vaccine pt reports a small red itchy area appeared on arm where she received her vaccine. Lasted 24 hours. On day 12 a large red, ithchy, warm to touch area appeared on arm where vaccine was given. Lasted four days then went away.
This spontaneous report as received from a registered nurse refers to a female patient of unknown age. The patient was vaccinated with a dose of PNEUMOVAX 23 (lot number reported as H018441, expired date; 28-FEB-2014). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced redness and swelling of arm at injection site. No treatment information was reported. The outcome of redness and swelling of arm at injection site was unknown. The relatedness for redness and swelling of arm at injection site was unknown for PNEUMOVAX 23. It was unknown if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Child received Boostrix and Menactra injection  - 2 minutes later - fainted. No external trauma, placed in reclined position, legs elevated, fluids given, BP taken elevated by doctor, released in good condition.
entire thigh grossly swollen;bright angry-red raised area approx 1 1/2cm by 2 1/2cm;heat palpable through patient clothes;
Her arm is hurting really bad today; the issue continued, and got worse, after she got the booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 60-year-old female patient received BNT162b2 (BNT162B2), on 05Oct2021 as dose 3 (booster), single (Lot number: FF8839) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (the second vaccine on 24Mar2021, and the Lot: EN6204), administration date: 24Mar2021, for Covid-19 Immunization, reaction(s): "Pain in arm"; Covid-19 vaccine (DOSE 1 , SINGLE, UNKNOWN MANUFACTURER), for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Her arm is hurting really bad today"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "the issue continued, and got worse, after she got the booster".
The first day that I had symptom, I was really tired. I didn't want to eat. I wasn't able to go on a hike with my family. That Saturday I stayed in bed a lot. I tested that Sunday and got a positive result. I went to urgent care that day and I got Paxlovid and took that for five days. I also took Advil for some achiness. I didn't have  a fever. I was hot and cold though. I continued that symptom for a bit. I do still have some lingering fatigue. I have been taking naps and I have never been a "napper"  in my life. I also still don't have an appetite.
Patient mom reported less than 24 hours after receiving 2nd dose of Moderna patient was found unresponsive with a fever and fingertips hot to touch. Patient also experienced a stiff neck and achy fingertips
Fever of 105.0, continuous screaming then lethargic; eyes had grey color & a mucous substance in eyes; broke out in small red bumps on face then spread to body; pt taken to emergency clinic & was ill for a wk;
After my first vaccine I experienced the usual headaches, tiredness and a left sore arm.  My right shoulder and right hip started to hurt and was becoming painful at times but I did not think anything of it.   After my second vaccine, I experienced left sore arm and about five days later my left hip pain and left shoulder pain again started to hurt. I had a hard time positioning myself in bed. Then when my pain started to go to my left side of my left shoulder I started to get concerned. On 04-09-2021, I stepped on a ladder and that is when I felt my hips a bit off. I went to see a doctor who told me I had reactive polyarthralgia in my joints. My doctor placed me on 20mg prednisone 2x a day.   I went to see my family doctor who did tests, all which were negative and one test showed that I had inflammation in my hip joints. I also had trouble getting dressed. My hips are better today, but I still cannot lift anything heavy. This week my family doctor put me on a Medrol dose pack and prednisone medication. I also started physical therapy the day before yesterday. At times I feel my right hip is worse than my left. I also feel my muscles are tight in my shoulders and have trouble grasping objects.
OBSTRUCTIVE SLEEP APNEA 3/28/2023 DISSECTION OF THORACOABDOMINAL AORTA
This spontaneous report as received from a pharmacist refers to multiple unspecified patients of unknown age and gender. Patients pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On unknown dates these unspecified patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (strength, dosing details, anatomical location, lot# and expiration date were unknown). No patients reported adverse effects. No product quality complaint was reported. This is one of the several reports from the same reporter. Additional information has been requested.
24 hrs post vax, severe pain under lower R rib cage, causing her to cry. No vomiting, fever. Also happened with first dose of Hep B although not as severe. Reported at time of 3rd dose which wasn't given.
Within a few minutes after receiving the vaccine, the following occurred. Portions of the left side of my tongue became numb. portions of the left side of my face became numb and some of the left side of my neck became numb.
After receiving vaccine I took a 3 mile walk. During the early morning I started getting chills, muscle aches and headache. Severe flu like symptoms. Nausea but didn?t vomit. Didn?t go to work. Couldn?t eat but forced myself to eat a few bites of toast so I could take Advil. 3 tablets, 200 mg. Helped muscle aches some but headache persisted. Ate toast and had decaf tea. Slept without chills and better today. To be expected have had injection  site pain but now also pain in armpit.
pt recvd vax; approx 2 wks later, pt exp watery eyes, itching, "bloodshot" eyes; called hlth dept & was instructed to see eye MD;saw MD & given atb eye drops; states was also exposed to gas fumes 2 days prior to eye problems;
Reported had a small red area at injection with soreness the day after injection.  A few days later developed a rash.  Now 13 days after injection still has a rash and itching at injection site 70mm round with erythema around edges.
Administered 10/10/14, went to urgent care 10/12/14 with red, swollen, warm 5 inch circle on right arm. Given 10 day course of KEFLEX on 10/12/14.
Warm, erythema, edema, tenderness at site of MMR/V injection. No fever, nausea/vomiting. Resolved within 72-96 hrs - was on Amoxicillin for sinusitis at time.
Onset of sx's 18 hrs fever, malaise, chills, aches, no local reaction 2nd day developed rash wheezing.
A non-serious spontaneous report of inadvertently given half dose of H1N1 was received from a nurse/health professional concerning a 33-year-old female. The patient's medical history and concomitant medications were not reported. On 27-Oct-2009, the patient was inadvertently given half dose (0.1 ml) of H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
a big red oval around the injection site; itchy; Sore arm /tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA, VACCINATION SITE PRURITUS, and VACCINATION SITE PAIN in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001021A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA, VACCINATION SITE PRURITUS, and VACCINATION SITE PAIN. At the time of the report, VACCINATION SITE ERYTHEMA, VACCINATION SITE PRURITUS, and VACCINATION SITE PAIN had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case concerns a 78-year-old female patient with no relevant medical history provided, who experienced the expected non-serious events of Vaccination site erythema, Vaccination site pruritus, and Vaccination site pain. The events occurred after the patient received the second dose of Moderna COVID-19, however the exact dates were not provided. Having in mind that the patient reported that these events also occurred after the patient received the booster dose, as well, the rechallenge is considered positive. The benefit-risk relationship of Moderna COVID-19 is not affected by this report.   This case was linked to MOD-2021-370338, MOD-2021-370374 (Patient Link). This case concerns a 78-year-old female patient with no relevant medical history provided, who experienced the expected non-serious events of Vaccination site erythema, Vaccination site pruritus, and Vaccination site pain. The events occurred after the patient received the second dose of Moderna COVID-19, however the exact dates were not provided. Having in mind that the patient reported that these events also occurred after the patient received the booster dose, as well, the rechallenge is considered positive. The benefit-risk relationship of Moderna COVID-19 is not affected by this report.
Rec'd telephone call from, father of child @ 5pm stating son Rec'd immunizations from health dept approximately 1 hr ago, complaining of difficulty breathing. Advised parent to talk to ER for evaluation ASAP. 11/15/05 TC no answer, left message on answering mach, for parent to call. 11/16/05 father states they went to ER and a nurse listened to his lungs and stated those were the best lungs she had heard all day. There was no congestion or wheezing. They waited on doctor for a while. Pt got to feeling OK so they left ER before he was seen by MD. Father states he is fine now.
RINGING IN LEFT EAR; SEVERE HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced severe headache. On 06-APR-2021 10:00, the subject experienced ringing in left ear. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe headache on APR-2021, and had not recovered from ringing in left ear. This report was non-serious.
Complaint of pain and swelling starting in the right leg and progressing through body.  Swollen glands in neck.
memory loss; First Primary monovalent dose on 08MAY2021 (Lot# 027C21A & Exp. Date: unknown).Shot #2: 2nd Primary monovalent dose on 09AUG2021; This spontaneous case was reported by a patient family member or friend and describes the occurrence of AMNESIA (memory loss) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary monovalent dose on 08MAY2021 (Lot# 027C21A & Exp. Date: unknown).Shot #2: 2nd Primary monovalent dose on 09AUG2021) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS7140C, 027C21A and 052E21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AMNESIA (memory loss) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary monovalent dose on 08MAY2021 (Lot# 027C21A & Exp. Date: unknown).Shot #2: 2nd Primary monovalent dose on 09AUG2021). At the time of the report, AMNESIA (memory loss) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary monovalent dose on 08MAY2021 (Lot# 027C21A & Exp. Date: unknown).Shot #2: 2nd Primary monovalent dose on 09AUG2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
I got Shingles.  Symptoms began on Thursday, April 15.  I am reading there is growing evidence that Covid vaccines trigger shingles.  I wanted you to know.
This spontaneous report as received from a pharmacist via a field representative refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with doses of PNEUMOVAX 23 (dose, route of administration, lot # and expiration date were not reported). On unknown dates, the patients experienced abnormally large injection site. The patients sought medical attention and received an unspecified treatment. The outcome of abnormally large injection site was unknown. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information has been received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 16-JUN-2011, the patient was inoculated with ZOSTAVAX vaccine (lot number, dosage and route of administration not provided) at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 21-NOV-2012, the patient was treated by a physician/MD at a clinic for a persistent vesicular rash, which was diagnosed as post-herpetic neuralgia, a chronic condition of pain and nerve damage secondary to herpes zoster infections. The patient was prescribed LIDODERM for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events is unknown. Additional information has been requested.
This spontaneous report was received from a reporter of an unspecified role (other) and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 25-APR-2017, the patient was vaccinated with a 0.65 mL dose of ZOSTAVAX injected subcutaneously in the left arm (lot # M038864 with expiration date at 12-DEC-2017), for prophylaxis, which was reconstituted in sterile diluent (STERILE DILUENT) (strength, dose, lot # and expiration date were not reported). On 27-APR-2017 (reported as "on the second day after injection"), the patient developed red, hot, raised, itchy, painful spot (about size of a quarter) on the arm at the injection site. The outcome of red, hot, raised, itchy, painful spot at the injection site was unknown at the time of the report. The causality assessment was not reported. Additional information has been requested.
Slight Neck Pain; sore arm; shoulder slight pain; slight fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Slight Neck Pain), PAIN IN EXTREMITY (sore arm), ARTHRALGIA (shoulder slight pain) and PYREXIA (slight fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Slight Neck Pain), PAIN IN EXTREMITY (sore arm), ARTHRALGIA (shoulder slight pain) and PYREXIA (slight fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Slight Neck Pain) and ARTHRALGIA (shoulder slight pain) had resolved and PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant treatment was provided. Patient was stated that after 3 weeks he had recovered from slight neck and shoulder ache. Patient had stated that he will going to take Pfizer on 18-AUG as Second dose